HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decreased 5-HT1A receptor binding in amygdala of schizophrenia.

AbstractBACKGROUND:
On the basis of postmortem data and the pharmacological action of atypical antipsychotics, serotonin-1A receptors are of interest in the study of the pathophysiology of schizophrenia. To investigate serotonin-1A receptors in schizophrenia and their relation to symptoms, we measured the availability of serotonin-1A receptors in patients with schizophrenia using positron emission tomography with [carbonyl-(11)C]WAY-100635.
METHODS:
Serotonin-1A receptor binding of 11 patients with schizophrenia (8 drug-naive and 3 drug-free) was compared with that of 22 age-matched and gender-matched healthy control subjects. Symptoms were assessed using the Positive and Negative Syndrome Scale. Serotonin-1A receptor binding in selected regions of interest was quantified by binding potential obtained by the reference tissue method.
RESULTS:
The regional binding potential value was lower in the amygdala by about 19% in patients with schizophrenia than in normal controls. A significant negative correlation was observed between binding potential in the amygdala and the negative and depression/anxiety symptom scores on the five-symptom subscale of the Positive and Negative Syndrome Scale.
CONCLUSIONS:
Decreased serotonin-1A receptor binding in the amygdala may underlie the affective components included in the symptoms of negative and depression/anxiety in schizophrenia.
AuthorsFumihiko Yasuno, Tetsuya Suhara, Tetsuya Ichimiya, Akihiro Takano, Tomomichi Ando, Yoshiro Okubo
JournalBiological psychiatry (Biol Psychiatry) Vol. 55 Issue 5 Pg. 439-44 (Mar 01 2004) ISSN: 0006-3223 [Print] United States
PMID15023569 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carbon Radioisotopes
  • Piperazines
  • Pyridines
  • Serotonin Antagonists
  • Receptor, Serotonin, 5-HT1A
  • N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide
Topics
  • Adult
  • Affective Symptoms (etiology, metabolism)
  • Amygdala (diagnostic imaging, metabolism)
  • Analysis of Variance
  • Anxiety (complications, metabolism)
  • Brain Mapping
  • Carbon Radioisotopes
  • Depression (complications, metabolism)
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Matched-Pair Analysis
  • Neuropsychological Tests
  • Piperazines
  • Pyridines
  • Receptor, Serotonin, 5-HT1A (metabolism)
  • Schizophrenia (complications, diagnostic imaging, metabolism)
  • Serotonin Antagonists
  • Tomography, Emission-Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: